...is a boutique technology firm that has been developing custom, world-class health care applications for over 15 years.
We put our hearts into every project.
IsoDynamic is thrilled to announce The Affinity, a new online adventure game designed to help kids make a real world friend.
IsoDynamic creates engaging, customized e-Learning experiences targeted to areas like autism, depression, and pharmaceuticals.
IsoDynamic creates custom database-driven Web applications in leading edge areas of health care like Pharmacogenomics.
IsoDynamic can help you with the Moodle Open-Source Learning Management System. Host your learning content at a fraction of the cost of a typical commercial system.
IsoDynamic is thrilled to announce the Beta release of a new online adventure game expressly designed to help kids make a friend in the real world. It's targeted to children ages 5-14 facing social challenges, including those on the autism spectrum. Kids who are wired a little differently.
NOW CALLING FOR BETA TESTERS - FOR A LIMITED TIME ONLY, IT'S FREE!
(1ST 30 SIGNUPS)
IsoDynamic has worked to develop unique e-Learning approaches to assist professionals when they are working with individuals and familes affected by Autism Spectrum Disorders.
IsoDynamic has assisted in the development of learning materials targeted to parents of young children with Autism Spectrum Disorders. Evidence has shown that early intervention can be effective.
IsoDynamic is thrilled to announce The Affinity, the first online adventure game designed to help a child make a real world friend.
Do carbohydrates cause Alzheimer's disease?
Percent of Annual Brain Loss Compared to Hb-A1c
Warfarindosing.org asks a physician or pharmacist to enter de-identified phenotypic and genetic (VKORC1 and CYP2C9 genes) patient information.
The warfarindosing.org application, developed by IsoDynamic, uses algorithms from Dr. Brian Gage to provide health care professionals with a best-practices dose estimate for the blood thinner warfarin.
The Genetics Informatics Trial (GIFT) is a study funded by the National Heart, Lung, and Blood Institute (NHLBI)
IsoDynamic created a custom expansion of the Warfarindosing.org application to meet the needs of this clinical trial in an effort to prevent adverse events from the dosing of this powerful blood thinner.
Iverson Genetics is a company dedicated to improving patient outcomes through personalized care.
IsoDynamic created a custom application for Iverson Genetics to implement their clinical trial and randomize patients to the correct arms of the study.
Genome Québec wanted to improve patient care by leveraging the work done on warfarindosing.org by Dr. Brian Gage and IsoDynamic
IsoDynamic developed a custom cloud service to the warfarindosing.org application so that Genome Québec could access the dosing algorithms and provide information to health care professionals within their current technology environment.